WDNA vs. PSCH

Last updated Aug 2, 2026

WDNA (WisdomTree BioRevolution Fund) and PSCH (Invesco S&P SmallCap Health Care ETF) are both Health & Biotech Equities funds - WDNA tracks the WisdomTree BioRevolution Index while PSCH tracks the S&P SmallCap 600 Health Care Index. Both are passively managed. Over the past 5 years, WDNA returned -4.37%/yr vs -2.96%/yr for PSCH. Their correlation of 0.82 means they have usually moved in the same direction. WDNA charges 0.45%/yr vs 0.29%/yr for PSCH.

Performance

WDNA vs. PSCH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WisdomTree BioRevolution Fund (WDNA) and Invesco S&P SmallCap Health Care ETF (PSCH). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, WDNA achieves a 15.26% return, which is significantly lower than PSCH's 21.19% return.

WDNA

• 1D: -2.29%
• 1M: -7.98%
• 6M: 8.18%
• YTD: 15.26%
• 1Y: 47.46%
• 3Y*: 4.46%
• 5Y*: -4.37%
• 10Y*: —
• ALL TIME*: -3.49%

PSCH

• 1D: -1.79%
• 1M: -0.73%
• 6M: 20.76%
• YTD: 21.19%
• 1Y: 40.46%
• 3Y*: 6.76%
• 5Y*: -2.96%
• 10Y*: 8.28%
• ALL TIME*: 12.46%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
PSCH Invesco S&P SmallCap Health Care ETF	$1.91M	$1.53M	$1.05M
WDNA WisdomTree BioRevolution Fund	$25.97K	$30.05K	$24.07K

WDNA vs. PSCH - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
WDNA WisdomTree BioRevolution Fund	15.26%	22.68%	-14.18%	-2.07%	-26.29%	-4.92%
PSCH Invesco S&P SmallCap Health Care ETF	21.19%	-0.49%	3.77%	-2.71%	-25.15%	-2.24%

Correlation

The correlation between WDNA and PSCH is 0.75, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.75
Correlation (3Y) Balances recent behavior with more history.	0.79
Correlation (5Y) Shows whether the relationship held over a longer period.	0.82
Correlation (All Time) Calculated using the full available price history since Jun 3, 2021	0.82

The correlation between WDNA and PSCH has been stable across timeframes, ranging from 0.75 to 0.82 - a consistent structural relationship.

WDNA vs. PSCH - Sectors Allocation Comparison

Sectors	WDNA	PSCH
Healthcare	90.0%	97.4%
Basic Materials	6.3%	-
Consumer Defensive	3.7%	-
Energy	1.1%	-
Communication Services	-	-
Consumer Cyclical	-	-
Financial Services	-	0.9%
Industrials	-	0.7%
Real Estate	-	-
Technology	-	1.0%
Utilities	-	-

Return for Risk

WDNA vs. PSCH — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

WDNA

WDNA Risk / Return Rank: 80
WDNA Sharpe Ratio Rank: 80
WDNA Sortino Ratio Rank: 80
WDNA Omega Ratio Rank: 72
WDNA Calmar Ratio Rank: 91
WDNA Martin Ratio Rank: 74

PSCH

PSCH Risk / Return Rank: 79
PSCH Sharpe Ratio Rank: 85
PSCH Sortino Ratio Rank: 86
PSCH Omega Ratio Rank: 81
PSCH Calmar Ratio Rank: 74
PSCH Martin Ratio Rank: 69

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

WDNA vs. PSCH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and Invesco S&P SmallCap Health Care ETF (PSCH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	WDNA	PSCH	Difference
Sharpe ratio: Return per unit of total volatility	1.84	1.99	-0.15
Sortino ratio: Return per unit of downside risk	2.61	2.87	-0.27
Omega ratio: Gain probability vs. loss probability	1.30	1.34	-0.04
Calmar ratio: Return relative to maximum drawdown	4.00	2.60	+1.40
Martin ratio: Return relative to average drawdown	9.29	8.34	+0.95

WDNA vs. PSCH - Sharpe Ratio Comparison

The current WDNA Sharpe Ratio is 1.84, which is comparable to the PSCH Sharpe Ratio of 1.99. The chart below compares the historical Sharpe Ratios of WDNA and PSCH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

WDNA vs. PSCH - Drawdown Comparison

The maximum WDNA drawdown since its inception was -58.87%, which is greater than PSCH's maximum drawdown of -46.32%. Use the drawdown chart below to compare losses from any high point for WDNA and PSCH.

Drawdown Indicators

	WDNA	PSCH	Difference
Max Drawdown Largest peak-to-trough decline	-58.87%	-46.32%	-12.55%
Max Drawdown (1Y) Largest decline over 1 year	-11.70%	-15.36%	+3.66%
Max Drawdown (3Y) Largest decline over 3 years	-36.65%	-22.98%	-13.67%
Max Drawdown (5Y) Largest decline over 5 years	-58.87%	-45.37%	-13.50%
Max Drawdown (10Y) Largest decline over 10 years	—	-46.32%	—
Current Drawdown Current decline from peak	-25.81%	-17.37%	-8.44%
Average Drawdown Average peak-to-trough decline	-35.30%	-13.52%	-21.78%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.03%	4.78%	+0.25%

Volatility

WDNA vs. PSCH - Volatility Comparison

WisdomTree BioRevolution Fund (WDNA) has a higher volatility of 7.04% compared to Invesco S&P SmallCap Health Care ETF (PSCH) at 5.03%. This indicates that WDNA's price experiences larger fluctuations and is considered to be riskier than PSCH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	WDNA	PSCH	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.04%	5.03%	+2.01%
Volatility (6M) Calculated over the trailing 6-month period	17.23%	14.67%	+2.56%
Volatility (1Y) Calculated over the trailing 1-year period	25.54%	20.16%	+5.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	25.26%	22.94%	+2.32%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.04%	23.64%	+1.40%

WDNA vs. PSCH - Expense Ratio Comparison

WDNA has a 0.45% expense ratio, which is higher than PSCH's 0.29% expense ratio.

Dividends

WDNA vs. PSCH - Dividend Comparison

WDNA's dividend yield for the trailing twelve months is around 3.96%, more than PSCH's 0.01% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
PSCH Invesco S&P SmallCap Health Care ETF	0.01%	0.04%	0.27%	0.01%	2.27%	0.00%	0.00%	0.00%	0.00%	0.00%	0.03%
WDNA WisdomTree BioRevolution Fund	3.96%	4.57%	0.75%	0.80%	0.38%	0.10%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both WDNA and PSCH in my portfolio?

WDNA and PSCH have a correlation of 0.75, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, WDNA or PSCH?

WDNA has higher volatility (7.04%) compared to PSCH (5.03%). In terms of maximum drawdown, WDNA dropped -58.87% vs PSCH's -46.32%.

Which ETF is better, WDNA or PSCH?

On 5-year performance, PSCH leads with -2.96% vs -4.37% for WDNA. On fees, PSCH is cheaper at 0.29% per year. On volatility, PSCH has been the lower-risk option at 5.03%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, WDNA or PSCH?

Over the 5-year period, PSCH has performed better with a -2.96% return vs -4.37%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, WDNA or PSCH?

PSCH is cheaper with a 0.29% expense ratio, compared with 0.45% for WDNA.

Which ETF pays a higher dividend yield, WDNA or PSCH?

WDNA has the higher dividend yield at 3.96%, compared with 0.01% for PSCH.

What is the main difference between WDNA and PSCH?

WDNA tracks WisdomTree BioRevolution Index, while PSCH tracks S&P SmallCap 600 Health Care Index. They also come from different issuers: WisdomTree and Invesco. Their fees differ too: 0.45% for WDNA and 0.29% for PSCH.

Which has better risk-adjusted returns?

PSCH currently has the higher Sharpe Ratio (1.99 vs 1.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.